Second Sight Medical (EYES) Reports Q2 Loss of $0.17/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Go back to Second Sight Medical (EYES) Reports Q2 Loss of $0.17/Share
July 28, 2016 4:06 PM EDT
SYLMAR, Calif.--(BUSINESS WIRE)--
Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or
"the Company"), a developer, manufacturer and marketer of implantable
visual prosthetics to provide some useful vision to blind patients,
today reported financial results for the three- and six-month periods
ended June 30, 2016.
Recent Company Highlights:
Completed oversubscribed Rights Offering, giving the Company access to
an additional $19.5 million to fund ongoing trials and research;
Generated net sales of $1.0 million in the second quarter of 2016
compared to $2.7 million in the second quarter of 2015;...
More
July 28, 2016 4:00 PM EDT
SYLMAR, Calif.--(BUSINESS WIRE)--
Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or
"the Company"), a developer, manufacturer and marketer of implantable
visual prosthetics to restore some useful vision to blind patients,
today announced plans to expand into Taiwan with Orient Europharma Co,
Ltd. and Iran with Arshia Gostar Darman Co, Ltd. through exclusive
agreements to distribute the Argus® II Retinal Prosthesis System ("Argus
II").
In Taiwan, Orient Europharma is a well-established distributor deeply
connected in the ophthalmology market. Taiwan is a densely populated
state of 25 million people. Their... More
